Download or read book New Developments in the Pharmacologic Treatment of Schizophrenia written by and published by . This book was released on 1992 with total page 182 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book New Developments in the Pharmacologic Treatment of Schizophrenia written by and published by . This book was released on 1992 with total page 165 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Pharmacologic Treatment of Schizophrenia written by Robert R. Conley and published by Professional Communications. This book was released on 2007-03 with total page 289 pages. Available in PDF, EPUB and Kindle. Book excerpt: A handbook for treating schizophrenia with antipsychotic drugs includes coverage of continuation and maintenance therapy and patient outcomes and economic evaluation data.
Download or read book Targets and Emerging Therapies for Schizophrenia written by Jeffrey S. Albert and published by John Wiley & Sons. This book was released on 2012-06-06 with total page 565 pages. Available in PDF, EPUB and Kindle. Book excerpt: New and emerging directions in pharmaceutical research to better treat schizophrenia Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases. Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potential new drugs and therapeutics. It begins with a discussion of prevalence and etiology. Then, it describes therapies such as dopamine agonists and phosphodiesterase (PDE) inhibitors as well as growing research aimed at addressing untreated symptoms. Next, the authors discuss receptor modulators, inhibitors, and targeting strategies for drug discovery. Both the neurobiological and chemical aspects of all major pharmacological targets are examined. With contributions from an international team of pioneering pharmaceutical researchers, this book compiles the current knowledge in the field, setting the stage for new breakthroughs in the treatment of schizophrenia. Targets and Emerging Therapies for Schizophrenia: Provides a comprehensive resource for neuro-drug discovery and the development of molecular targets for schizophrenia treatment Draws from chemistry, biology, and pharmacology for more effective drug targeting and discovery Explores a wide range of receptors and molecular targets, including dopamine, PDEs, and neuropeptides With Targets and Emerging Therapies for Schizophrenia as their guide, drug discovery and development scientists have the information they need to advance their own research so that new, more effective treatments for schizophrenia will soon be a reality.
Download or read book First Episode Psychosis written by Katherine J. Aitchison and published by CRC Press. This book was released on 1999-02-17 with total page 152 pages. Available in PDF, EPUB and Kindle. Book excerpt: The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management.
Download or read book Pharmacological Treatment of Mental Disorders in Primary Health Care written by World Health Organization and published by World Health Organization. This book was released on 2009 with total page 80 pages. Available in PDF, EPUB and Kindle. Book excerpt: This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.
Download or read book Drug Discovery for Schizophrenia written by Tatiana V. Lipina and published by Royal Society of Chemistry. This book was released on 2015-05-13 with total page 304 pages. Available in PDF, EPUB and Kindle. Book excerpt: Since the pioneering pharmacotherapy for treatment of schizophrenia in the 1950s by antipsychotics, only a few major innovations have been made, pointing to a general stagnation in the field of pharmacology of schizophrenia. Drug Discovery for Schizophrenia covers new insights in the field of schizophrenia with an aim to advance the understanding of scientists and clinicians in this area and to fuel drug discovery. The book outlines a change in the way schizophrenia is treated by moving away from focusing only on treating symptoms in patients. Innovative drugs emerge from deeper comprehension of the pathological processes that emerge earlier in life, hence, providing strategies for preventative therapy to alter the course of this mental disorder. Amongst other current topics, the book covers new findings in genetics and epigenetics, progress in animal models for schizophrenia and the usage of induced pluripotent stem cells. The combination of these important areas benefit psychiatric neuroscience, filling the gaps in the knowledge of neurobiology of schizophrenia and providing novel perspectives for future drug development.
Download or read book Antipsychotic Trials in Schizophrenia written by T. Scott Stroup and published by Cambridge University Press. This book was released on 2010-04-01 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: Antipsychotic medications are a key treatment for schizophrenia and sales of antipsychotic drugs approach $20 billion per year, with fierce marketing between the makers of the drugs. The U.S. National Institute of Mental Health sponsored the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project to provide independent information about the comparative effectiveness of medications. CATIE was the largest, longest and most comprehensive study of schizophrenia to date. Conducted under rigorous double-blind conditions, Antipsychotic Trials in Schizophrenia presents the definitive archival results of this landmark study. The core of the book consists of chapters focused on specific outcomes that set the CATIE findings in a wider context. Also included are chapters on the design, statistical analyses and implications for researchers, clinicians and policy makers. Psychiatrists, psychiatric researchers, mental health policy makers and those working in pharmaceutical companies will all find this to be essential reading.
Download or read book Comprehensive Care of Schizophrenia written by Jeffrey A. Lieberman and published by Oxford University Press. This book was released on 2012-04-04 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: The body of knowledge that we have accumulated about the causes and nature of schizophrenia is prodigious, and the repertoire of evidence-based treatments is substantial and increasing. Comprehensive Care of Schizophrenia distills this corpus into the essential information that clinicians who care for persons with schizophrenia need to know. The second edition of the popular volume is thoroughly updated, offering new information on the advances in research and management since the first edition was published a decade ago. Chapters are streamlined to keep content as concise as possible, while key sections have been revised and expanded to include new information on drug therapy and advice on patient care. People with schizophrenia can suffer from multiple morbidities and disabilities, and thus may require a variety of treatments, both pharmacological and psychosocial. To cover the complex and growing field of schizophrenia management, renowned psychiatrists Jeffrey Lieberman and Robin Murray have recruited a distinguished group of researchers, practitioners and consumers of mental health care. This guide delves into to all aspects of the clinical management of schizophrenia for both the health care professional who treats patients as well as the researcher interested in the advances made in the field and their clinical application.
Download or read book Non Pharmacological Interventions for Schizophrenia How Much Can Be Achieved and How written by Christina Andreou and published by Frontiers Media SA. This book was released on 2017-01-10 with total page 96 pages. Available in PDF, EPUB and Kindle. Book excerpt: The introduction of antipsychotic agents in the 1950’s substantially improved the treatment of schizophrenia and other psychotic disorders. However, clinical and functional outcomes are still far less than optimal for patients, and have not improved in recent years despite the development of several new antipsychotics. Efficacy rates are further compromised by medication non-adherence, which has been reported to affect more than half of patients. In response to these issues, several non-pharmacological interventions have been developed for the treatment of schizophrenia, such as cognitive behavioral therapy, cognitive remediation, social cognition training and metacognitive approaches. Although these interventions have produced promising results, there is still much controversy regarding their usefulness and applicability in clinical practice. A major impeding factor for their dissemination is possibly a lack of sufficient evidence regarding their specific indications, mechanisms of action, adverse effects, but also practical issues concerning the interpretability of respective clinical studies, such as the choice of outcome variables and control of confounding factors. The present Research Topic includes original research articles and reviews addressing these issues.
Download or read book Schizophrenia written by A. A. Schiff and published by . This book was released on 1985 with total page 142 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Schizophrenia Bulletin written by and published by . This book was released on 2010 with total page 602 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Antipsychotics written by John G. Csernansky and published by Springer. This book was released on 2012-02-22 with total page 539 pages. Available in PDF, EPUB and Kindle. Book excerpt: Antipsychotic drugs were first discovered in 1953, and not since the late 1970s has the Handbook of Experimental Pharmacology taken up this topic. A new treatment of this topic would be due under any circumstances; however, this is now particularly true, since remarkable progress has been made on several fronts in furthering our understanding of the mechanisms of antipsychotic drug action. First, we have learned that schizophrenia is an illness with particu lar neuroanatomical abnormalities, many of which suggest that the illness is caused by errors in neurodevelopment. These findings have helped to form a context for understanding neurochemical aberrations in the illness and suggest new approaches for pharmacological treatment. Propelled forward by rapid advances in neurochemical anatomy, current pathophysiological hypotheses of schizophrenia and antipsychotic drug action have taken on the appearance of complex electrical circuit diagrams. Second, molecular biology studies have now revealed that there is a multiplicity of dopamine receptors (i. e. , D , DZshort' j DZlong, D , D , and D ), some of which may become entirely new targets for 3 4 s antipsychotic drug action. Ironically, the development of drugs that are selec tive for these receptors and that can be used to investigate their function lags behind; yet the discovery of these new receptors offers unparalleled opportu nities for developing drugs with improved efficacy and fewer side effects.
Download or read book New Oxford Textbook of Psychiatry written by Michael G. Gelder and published by . This book was released on 2000 with total page 2131 pages. Available in PDF, EPUB and Kindle. Book excerpt: This two volume set is the definitive source for all practising psychiatrists. It covers all areas of general psychiatry in depth, and includes sections on each of the subspecialties including child psychiatry and forensic psychiatry.
Download or read book Practice Guideline for the Treatment of Patients with Schizophrenia written by American Psychiatric Association and published by American Psychiatric Publishing. This book was released on 1997 with total page 164 pages. Available in PDF, EPUB and Kindle. Book excerpt: The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
Download or read book Schizophrenia and Mood Disorders written by Peter Buckley and published by CRC Press. This book was released on 2000-06-05 with total page 368 pages. Available in PDF, EPUB and Kindle. Book excerpt: This authoritative reference draws upon, and combines the similarities and differences between European and American practices in the diagnosis and treatment of mood disorders and schizophrenia to provide an international approach to drug therapies. By including the most up-to-date knowledge, best practices, and clinical pearls from each continent, the editors and the 48 international expert contributors have ensured that this is a critical resource for clinicians prescribing for their patients. The first two sections address the use of a variety of antipsychotic medications for the treatment of schizophrenia, and the clinical use of antidepressant medications and mood stabilizers for depression and mania. The authors discuss their experiences of treatment using some of the most recently available drugs and others which are currently under development. The key issues of concern to the clinician, and broader topics of clinical psychopharmacology, are addressed in the final section which covers underlying principles and offers practical advice.
Download or read book Schizophrenia Into Later Life written by Carl I. Cohen and published by American Psychiatric Pub. This book was released on 2008-05-20 with total page 343 pages. Available in PDF, EPUB and Kindle. Book excerpt: We are on the verge of a crisis in mental health. Over the next 30 years the number of chronically mentally ill people 55 years of age and older will double. With multiple disorders relating to mental illness and old age, these people will require unique services from a health care system that is ill prepared to deliver them. Schizophrenia Into Later Life: Treatment, Research, and Policy is the first major multidisciplinary reference on this important topic -- a landmark work for researchers, service providers, and policy makers. Broad in scope, it discusses the demographic and clinical characteristics of older schizophrenic persons, details treatment approaches, suggests research strategies, and covers the relevant economic and health policy issues. The most up-to-date, comprehensive source of information on this understudied group. It will help community psychiatrists, gerontologists, psychologists, policy makers, and social scientists meet a growing demand for services. A multidisciplinary approach with contributing experts from fields of biological psychiatry, social psychiatry, sociology, anthropology, social work, psychology, and neuropsychology will help professionals integrate services for the best outcome. A primary resource on the subject -- sections include epidemiology, biological aspects, psychosocial features, clinical care, and public policy. Today there is a distressing lack of age-appropriate clinical, rehabilitative, or residential programs for older patients with chronic mental illness. Schizophrenia in Later Life: Treatment, Research, and Policy will guide researchers, service providers, and policy makers in creating innovative new programs to help this underserved and growing population.
